EUA
Aptima SARS-CoV-2/Flu assay
FDA Emergency Use Authorization · Hologic, Inc. · Feb 14, 2023
Key facts
| Product | Aptima SARS-CoV-2/Flu assay |
|---|---|
| Company | Hologic, Inc. |
| Product type | Real-time TMA, chemiluminescent, Multi-analyte, Multiple Targets |
| Date | Feb 14, 2023 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: